Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07570459

TREMOR IN CHARCOT-MARIE-TOOTH

Tremor is a symptom that has already been described in many case reports and case series concerning patients with Charcot-Marie-Tooth (CMT) disease. However, the pathophysiology of tremor in this condition remains largely unclear. It has also not been sufficiently investigated to what extent tremor in CMT patients constitutes a relevant impairment of quality of life.

This project focuses on a more detailed characterization of tremor in CMT patients using surface electromyography and accelerometer analysis, as well as the collection of individual clinical data, particularly regarding the symptom of tremor, in order to facilitate the characterization and etiological classification of the tremor. In addition, a questionnaire-based assessment will be conducted to capture the impact of tremor on activities of daily living and the associated burden in this specific patient cohort.

The entire data collection process will be supported by a clinical examination, which will be video-recorded by experienced neurologists to ensure more reliable analysis. This serves both the characterization of tremor and the illustration of its functional limitations. Where available, the data will be correlated with genetic variants to allow conclusions about possible genetic predispositions or disease progression. As a control group, CMT patients who have not yet reported a tremor will be included.

Recruiting

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical CMT Diagnosis / Anamnestically Healthy Control Group
  • Genetic confirmation of CMT in adult patients
  • Ability to achieve the outcome measure at baseline
  • Age between 18 and 65 years
  • Capacity of all study participants to consent and signed informed consent, including patient or participant information and consent form

Exclusion criteria

  • Pregnancy or breastfeeding period
  • Other relevant neurological or psychiatric disorders, acute or in the past history
  • Presence of a serious previous internal disease

Treatment and study plan

Primary outcomes

  1. Activities of Daily Living -Questionaire(ADL)

    Time frame: baseline

  2. Assessment of Handicap - Questionaire

    Time frame: baseline

  3. Fahn Tolosa Marin Rating Scale

    Time frame: baseline

  4. Electrophysiological characterization of tremor using surface EMG and accelerometer analysis

    Time frame: baseline

Secondary outcomes

  1. MDS-UPDRS Part III without Tremor

    Time frame: baseline

  2. SARA Score

    Time frame: baseline

Study contacts

Contact information is provided by the study sponsor or research team.

Michael W Sereda, Prof. MD

CONTACT

[email protected]

+49 551 3964162

Sponsors and collaborators

Lead sponsor

University Medical Center Goettingen

Other

Registry information

Official study title

Investigation of Tremor in Patients With Charcot-Marie-Tooth Neuropathy

Acronym: CMT-TREM

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
May 6, 2026
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.